Latest News from Pro PG

When a medicine becomes unavailable in Australia, several access pathways may be relevant. This guide explains Section 19A, SAS Categories A, B and C, Authorised Prescriber and the practical realities of sourcing overseas medicines.

Fludarabine Phosphate Injection, USP 50mg/2mL (25mg/mL) Single-Dose Vial (Fresenius Kabi, USA)

Dear Healthcare Professional, Shortage of CYSTAGON mercaptamine (cysteamine) (as bitartrate) 150 mg capsule bottle (AUST R: 60452) Pro Pharmaceuticals Group recognises the importance of maintaining access to essential medicines in Australia and would like to advise healthcare professionals of an alternative supply arrangement for CYSTAGON 150 mg capsules. The Australian-registered medicine, CYSTAGON mercaptamine (cysteamine) (as bitartrate) 150 mg capsule bottle (AUST R: 6045

Dear Healthcare Professional, Shortage of FLUDARABINE JUNO fludarabine phosphate 50 mg powder for injection vial (AUST R: 147831) Pro Pharmaceuticals Group recognises the importance of maintaining access to essential medicines in Australia and would like to provide an update regarding the supply of fludarabine phosphate injection. The Australian-registered medicine, FLUDARABINE JUNO fludarabine phosphate 50 mg powder for injection vial (AUST R: 147831), sponsored by Juno Pha

Why do medicines run short? Follow the pharmaceutical supply chain from manufacturing and batch release to the hospital ward, and discover why medicine shortages occur and how alternative supply pathways can help maintain patient access.

Shortage of BICILLIN L-A benzathine benzylpenicillin

Early signs of supply tightening are beginning to emerge across global medicine supply chains, despite no significant increase in official shortage notifications. In practice, disruption appears first in supplier behaviour, lead times, and freight complexity—well before it is reflected in formal data.

Dear Healthcare Professional, Shortage of DEPTRAN 10 doxepin 10mg (as hydrochloride) capsule blister pack (AUST R: 308999) Pro Pharmaceuticals Group recognises the importance of supplying essential medicines in Australia and would like to advise you the change in supply status of DEPTRAN 10 doxepin 10mg (as hydrochloride) capsule blister pack (AUST R: 308999) in Australia. The Australian registered medicine, DEPTRAN 10 doxepin 10mg (as hydrochloride) capsule blister pac

Australian registered LARIAM® mefloquine 250 mg tablets are currently in limited availability. The TGA has granted Section 19A approval for temporary supply of Mefloquine Hydrochloride 250 mg tablets from Canada to ensure continuity of malaria treatment and prophylaxis. Pro Pharmaceuticals Group now supports supply to Australian healthcare institutions.

Pro Pharmaceuticals Group has launched a new initiative to support hospitals with early visibility on emerging medicine supply pressures. This service strengthens planning, improves continuity, and helps clinical teams stay ahead of potential disruptions.